Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000248176 | SCV000319869 | likely benign | Cardiovascular phenotype | 2015-07-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000379802 | SCV000343902 | uncertain significance | not provided | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001084888 | SCV000562870 | benign | Long QT syndrome | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000379802 | SCV001945136 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000379802 | SCV003800101 | likely benign | not provided | 2022-11-02 | criteria provided, single submitter | clinical testing |